Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report

Cellular Oncology

Volumn 38, Issue 2, 2015, Pages 165-172

  Peng, Hui ^a,b   Huang, Jun ^a,c   Hu, Ying ^d   Wei, Yisheng ^e   Liu, Huanliang ^a   Huang, Meijin ^a,b   Wang, Lei ^a,b   Wang, Jianping ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Single nucleotide polymorphism; Spleen tyrosine kinase gene promoter

Indexed keywords

PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84928537447     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0208-2     Document Type: Article

References (29)

1. T. Cacev, G. Aralica, B. Loncar, S. Kapitanovic, Loss of NF2/Merlin expression in advanced sporadic colorectal cancer. Cell. Oncol. 37, 69–77 (2014)
2. S.D. Markowitz, M.M. Bertagnolli, Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460 (2009)
3. Z. Yang, L. Huo, H. Chen, B. Ni, J. Xiang, L. Kang, L. Wang, J. Peng, Y. Yuan, J. Wang, Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Med. Oncol. 30, 586 (2013)
4. L. Duan, L. Ye, G. Zhao, Z. Wu, C. Jin, X. Cai, G. Li, Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. Eur. J. Cardiothorac. Surg.: Off. J. Eur. Asso. Cardiothorac. Surg. 43, e58–63 (2013)
5. S. Luangdilok, C. Box, L. Patterson, W. Court, K. Harrington, L. Pitkin, P. Rhys-Evans, P. O-charoerat, S. Eccles, Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res. 67, 7907–7916 (2007)
6. U. Inayat, M.A. Kayani, R. Faryal, Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report. Polish J. Path.: Off. J. Polish Soc. Path. 63, 106–111 (2012)
7. C. Peng, Q. Sun, Y. Hao, B. Cong, Y. Zhao, X. Zhao, Syk is low-expressed in non-small-cell lung cancer and inversely correlates with patient’s survival. Acta Biochim. Biophys. Sin. 45, 149–151 (2013)
8. L. Wang, E. Devarajan, J. He, S.P. Reddy, J.L. Dai, Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Cancer Res. 65, 10289–10297 (2005)
9. O. Bailet, N. Fenouille, P. Abbe, G. Robert, S. Rocchi, N. Gonthier, C. Denoyelle, M. Ticchioni, J.P. Ortonne, R. Ballotti, M. Deckert, S. Tartare-Deckert, Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res. 69, 2748–2756 (2009)
10. T. Layton, C. Stalens, F. Gunderson, S. Goodison, S. Silletti, Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. Am. J. Pathol. 175, 2625–2636 (2009)
11. S. Ogane, T. Onda, N. Takano, T. Yajima, T. Uchiyama, T. Shibahara, Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma. Int. J. Cancer. J. Int. du Cancer 124, 2651–2657 (2009)
12. A. Yousuf, M.Y. Bhat, A.A. Pandith, D. Afroze, N.P. Khan, K. Alam, P. Shah, M.A. Shah, S. Mudassar, MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–252 (2014)
13. J.S. de Groot, X. Pan, J. Meeldijk, E. van der Wall, P.J. van Diest, C.B. Moelans, Validation of DNA promoter hypermethylation biomarkers in breast cancer–a short report. Cell. Oncol. 37, 297–303 (2014)
14. E. Yiannakopoulou, Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents–implications for cancer treatment and chemoprevention. Cell. Oncol. 37, 167–178 (2014)
15. M. Sabir, R.M. Baig, K. Ali, I. Mahjabeen, M. Saeed, M.A. Kayani, Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer. Cell. Oncol. 37, 203–213 (2014)
16. B. Bessenyei, M. Marka, L. Urban, M. Zeher, I. Semsei, Single nucleotide polymorphisms: aging and diseases. Biogerontology 5, 291–303 (2004)
17. L. Ma, S. Dong, P. Zhang, N. Xu, H. Yan, H. Liu, Y. Li, Q. Zhou, The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Clin. Lab. 56, 407–416 (2010)
18. C. Yan, C. Liu, Q. Jin, Z. Li, B. Tao, Z. Cai, The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncol. Lett. 4, 505–508 (2012)
19. N.A. Mundell, J.L. Plank, A.W. LeGrone, A.Y. Frist, L. Zhu, M.K. Shin, E.M. Southard-Smith, P.A. Labosky, Enteric nervous system specific deletion of Foxd3 disrupts glial cell differentiation and activates compensatory enteric progenitors. Dev. Biol. 363, 373–387 (2012)
20. A.S. Cheng, M.S. Li, W. Kang, V.Y. Cheng, J.L. Chou, S.S. Lau, M.Y. Go, C.C. Lee, T.K. Ling, E.K. Ng, J. Yu, T.H. Huang, K.F. To, M.W. Chan, J.J. Sung, F.K. Chan, Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144, 122–133 (2013). e129
21. D. Hoffmann, I. Hoffmann, K. El-Bayoumy, The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14, 767–790 (2001)
22. S. Raimondi, E. Botteri, S. Iodice, A.B. Lowenfels, P. Maisonneuve, Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat. Res. 670, 6–14 (2009)
23. A. Pfohl-Leszkowicz, Y. Grosse, V. Carriere, P.H. Cugnenc, A. Berger, F. Carnot, P. Beaune, I. de Waziers, High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res. 55, 5611–5616 (1995)
24. J.N. Poynter, R.W. Haile, K.D. Siegmund, P.T. Campbell, J.C. Figueiredo, P. Limburg, J. Young, L. Le Marchand, J.D. Potter, M. Cotterchio, G. Casey, J.L. Hopper, M.A. Jenkins, S.N. Thibodeau, P.A. Newcomb, J.A. Baron, R. Colon, Cancer family, associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol. Biomarkers Prev. 18, 2745–2750 (2009)
25. L.C. Thygesen, K. Wu, M. Gronbaek, C.S. Fuchs, W.C. Willett, E. Giovannucci, Alcohol intake and colorectal cancer: a comparison of approaches for including repeated measures of alcohol consumption. Epidemiology 19, 258–264 (2008)
26. A.T. Toriola, S. Kurl, J.A. Laukanen, C. Mazengo, J. Kauhanen, Alcohol consumption and risk of colorectal cancer: the Findrink study. Eur. J. Epidemiol. 23, 395–401 (2008)
27. E.M. Siegel, C.M. Ulrich, E.M. Poole, R.S. Holmes, P.B. Jacobsen, D. Shibata, The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control: J. Moffitt Cancer Center 17, 52–57 (2010)
28. G. Gonullu, H. Kahraman, A. Bedir, A. Bektas, I. Yucel, Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int. J. Color. Dis. 25, 205–212 (2010)
29. S. Yamamoto, T. Nakagawa, Y. Matsushita, S. Kusano, T. Hayashi, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 33, 184–189 (2010)